Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00898742 · clinicaltrials.gov ↗

TERMINATED

Status

58

Enrollment

OTHER

Sponsor class

Stopped study closed prematurely upon PI's departure from VICC

Conditions

Head and Neck Cancer

Interventions

GENETIC: DNA and tissue microarray analysis
GENETIC: reverse transcriptase-polymerase chain reaction
OTHER: mass spectrometry

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]